InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

8.59
Delayed Data
As of Apr 20
 +0.34 / +4.12%
Today’s Change
7.71
Today|||52-Week Range
106.25
-55.38%
Year-to-Date
No recent news for InVivo Therapeutics Holdings Corp.

Today’s Trading

Previous close8.25
Today’s open8.24
Day’s range8.21 - 8.75
Volume9,138
Average volume (3 months)21,894
Market cap$24.7M
Data as of 3:59pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+39.68%
Earnings growth (this year)-6.41%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.80

Competitors

 Today’s
change
Today’s
% change
CLBSCaladrius Bioscience...+0.11+2.43%
ALPNAlpine Immune Scienc...-0.27-3.30%
MTEMMolecular Templates ...-0.14-1.60%
CSBRChampions Oncology I...0.000.00%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 4, 2018
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$0.00
Annual profit (last year)-$23.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Richard Toselli
Senior Vice President-
Operations
William D'Agostino
Corporate headquarters
Cambridge, Massachusetts

Forecasts